| In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR) A Guldbrandsen, H Vethe, Y Farag, E Oveland, H Garberg, M Berle, ... Molecular & cellular proteomics 13 (11), 3152-3163, 2014 | 146 | 2014 |
| Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls AC Kroksveen, A Guldbrandsen, C Vedeler, KM Myhr, JA Opsahl, ... Acta Neurologica Scandinavica 126, 90-96, 2012 | 82 | 2012 |
| Cerebrospinal fluid proteomics in multiple sclerosis AC Kroksveen, JA Opsahl, A Guldbrandsen, KM Myhr, E Oveland, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1854 (7), 746-756, 2015 | 38 | 2015 |
| In-depth cerebrospinal fluid quantitative proteome and deglycoproteome analysis: presenting a comprehensive picture of pathways and processes affected by multiple sclerosis AC Kroksveen, A Guldbrandsen, M Vaudel, RR Lereim, H Barsnes, ... Journal of proteome research 16 (1), 179-194, 2017 | 37 | 2017 |
| CSF-PR 2.0: an interactive literature guide to quantitative cerebrospinal fluid mass spectrometry data from neurodegenerative disorders A Guldbrandsen, Y Farag, AC Kroksveen, E Oveland, RR Lereim, ... Molecular & Cellular Proteomics 16 (2), 300-309, 2017 | 34 | 2017 |
| Label‐free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis JA Opsahl, M Vaudel, A Guldbrandsen, E Aasebø, V Van Pesch, ... Proteomics 16 (7), 1154-1165, 2016 | 30 | 2016 |
| Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis E Oveland, I Ahmad, RR Lereim, AC Kroksveen, H Barsnes, ... Scientific Reports 11 (1), 7174, 2021 | 20 | 2021 |
| Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis A Guldbrandsen, RR Lereim, M Jacobsen, H Garberg, AC Kroksveen, ... Clinical proteomics 17, 1-21, 2020 | 10 | 2020 |
| Protein post-translational modification crosstalk in acute myeloid leukemia calls for action M Hernandez-Valladares, R Wangen, FS Berven, A Guldbrandsen Current Medicinal Chemistry 26 (28), 5317-5337, 2019 | 10 | 2019 |
| In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR) Mol Cell Proteomics. 2014; 13: 3152–3163. doi: 10.1074/mcp A Guldbrandsen, H Vethe, Y Farag, E Oveland, H Garberg, M Berle, ... M114 38554, 0 | 7 | |
| A simple workflow for large scale shotgun glycoproteomics A Guldbrandsen, H Barsnes, AC Kroksveen, FS Berven, M Vaudel Proteomics in Systems Biology: Methods and Protocols, 275-286, 2016 | 5 | 2016 |
| Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR) A Guldbrandsen, YM Farag, RR Lereim, FS Berven, H Barsnes Cerebrospinal Fluid (CSF) Proteomics: Methods and Protocols, 377-391, 2019 | 1 | 2019 |
| Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis RR Lereim, P Nytrova, A Guldbrandsen, EK Havrdova, KM Myhr, ... Plos one 19 (3), e0300914, 2024 | | 2024 |
| Review of Research and Assessment - Empirical research on Scandinavian early childhood education and care in 2020 A Guldbrandsen, MI Furenes, E Munthe https://www.nb-ecec.org/kortlaegninger/rapportnb-ecec-eng-2020.pdf, 2023 | | 2023 |
| Supplementary methods Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis E Oveland, I Ahmad, RR Lereim, AC Kroksveen, H Barsnes, ... | | |
| Alpízar, Adan, 181 Barsnes, Harald, 300 Beekman, Marian, 228 Bell, Thomas W., 157 FS Berven, BT Bikman, A Bondt, M Boonen, G Britton, AL Burlingame, ... | | |
| Technological Innovation and Resources A Guldbrandsen, Y Farag, AC Kroksveen, E Oveland, RR Lereim, ... | | |
